Pluri, Inc. (PLUR)
1.18
-0.06
(-4.48%)
USD |
NASDAQ |
Nov 09, 16:00
1.18
0.00 (0.00%)
After-Hours: 19:36
Pluri Enterprise Value : 46.05M for Nov. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 46.05M |
| November 05, 2026 | 45.56M |
| November 04, 2026 | 46.00M |
| November 03, 2026 | 46.43M |
| November 02, 2026 | 45.67M |
| October 30, 2026 | 46.11M |
| October 29, 2026 | 45.67M |
| October 28, 2026 | 46.00M |
| October 27, 2026 | 45.56M |
| October 26, 2026 | 44.81M |
| October 23, 2026 | 43.40M |
| October 22, 2026 | 43.62M |
| October 21, 2026 | 44.05M |
| October 20, 2026 | 42.42M |
| October 19, 2026 | 41.88M |
| October 16, 2026 | 42.75M |
| October 15, 2026 | 42.86M |
| October 14, 2026 | 42.75M |
| October 13, 2026 | 42.86M |
| October 12, 2026 | 43.18M |
| October 09, 2026 | 43.00M |
| October 08, 2026 | 43.51M |
| October 07, 2026 | 43.94M |
| October 06, 2026 | 43.40M |
| October 05, 2026 | 43.89M |
| Date | Value |
|---|---|
| October 02, 2026 | 43.62M |
| October 01, 2026 | 43.83M |
| September 30, 2026 | 43.51M |
| September 29, 2026 | 43.60M |
| September 28, 2026 | 43.18M |
| September 25, 2026 | 43.62M |
| September 24, 2026 | 44.05M |
| September 23, 2026 | 44.16M |
| September 22, 2026 | 44.59M |
| September 21, 2026 | 44.26M |
| September 18, 2026 | 44.37M |
| September 17, 2026 | 44.37M |
| September 16, 2026 | 45.02M |
| September 15, 2026 | 45.39M |
| September 14, 2026 | 46.11M |
| September 11, 2026 | 45.46M |
| September 10, 2026 | 46.21M |
| September 09, 2026 | 47.51M |
| September 08, 2026 | 46.43M |
| September 04, 2026 | 47.40M |
| September 03, 2026 | 47.51M |
| September 02, 2026 | 48.05M |
| September 01, 2026 | 48.49M |
| August 31, 2026 | 48.59M |
| August 28, 2026 | 49.24M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Compugen Ltd. | 63.38M |
| Evogene Ltd. | 5.476M |
| Scinai Immunotherapeutics Ltd. | 7.709M |
| CollPlant Biotechnologies Ltd. | 5.443M |
| Regentis Biomaterials Ltd. | 50.73M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.193M |
| Revenue (Quarterly) | 0.335M |
| Total Expenses (Quarterly) | 6.215M |
| EPS Diluted (Quarterly) | -0.5432 |
| Gross Profit Margin (Quarterly) | 21.49% |
| Profit Margin (Quarterly) | -1.85K% |
| Earnings Yield | -207.8% |
| Normalized Earnings Yield | -209.62 |